INACTIVATE NOTCH1 inactivating mutations are present in 11-19% of HNSCC, suggesting that NOTCH1 may behave as a tumor suppressor in contrast to its proto-oncogenic role in other cancers (1,3-10,12,13). This evidence concerns the gene NOTCH1 and head and neck squamous cell carcinoma.